Plasmodium vivax Duffy binding protein: baseline antibody responses and parasite polymorphisms in a well-consolidated settlement of the Amazon Region
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
21/08/2013
21/08/2013
01/08/2012
|
Resumo |
Objective To investigate risk factors associated with the acquisition of antibodies against Plasmodium vivax Duffy binding protein (PvDBP) a leading malaria vaccine candidate in a well-consolidated agricultural settlement of the Brazilian Amazon Region and to determine the sequence diversity of the PvDBP ligand domain (DBPII) within the local malaria parasite population. Methods Demographic, epidemiological and clinical data were collected from 541 volunteers using a structured questionnaire. Malaria parasites were detected by conventional microscopy and PCR, and blood collection was used for antibody assays and molecular characterisation of DBPII. Results The frequency of malaria infection was 7% (6% for P. vivax and 1% for P. falciparum), with malaria cases clustered near mosquito breeding sites. Nearly 50% of settlers had anti-PvDBP IgG antibodies, as detected by enzyme-linked immunosorbent assay (ELISA) with subjects age being the only strong predictor of seropositivity to PvDBP. Unexpectedly, low levels of DBPII diversity were found within the local malaria parasites, suggesting the existence of low gene flow between P. vivax populations, probably due to the relative isolation of the studied settlement. Conclusion The recognition of PvDBP by a significant proportion of the community, associated with low levels of DBPII diversity among local P. vivax, reinforces the variety of malaria transmission patterns in communities from frontier settlements. Such studies should provide baseline information for antimalarial vaccines now in development. Research Foundation of Minas Gerais State (FAPEMIG) Research Foundation of Minas Gerais State (FAPEMIG) Research Foundation of Amazonas State (FAPEAM) Research Foundation of Amazonas State (FAPEAM) Brazilian National Research Council (CNPq) Brazilian National Research Council (CNPq) Pronex Malaria/CNPq/DECIT/MS Pronex Malaria/CNPq/DECIT/MS |
Identificador |
TROPICAL MEDICINE & INTERNATIONAL HEALTH, HOBOKEN, v. 17, n. 8, supl. 1, Part 4, pp. 989-1000, AUG, 2012 1360-2276 http://www.producao.usp.br/handle/BDPI/32640 10.1111/j.1365-3156.2012.03016.x |
Idioma(s) |
eng |
Publicador |
WILEY-BLACKWELL HOBOKEN |
Relação |
TROPICAL MEDICINE & INTERNATIONAL HEALTH |
Direitos |
closedAccess Copyright WILEY-BLACKWELL |
Palavras-Chave | #PLASMODIUM VIVAX #DUFFY BINDING PROTEIN #ANTIBODIES #POLYMORPHISMS #FRONTIER SETTLEMENT #P #VIVAX #PROTEINE DE LIAISON DUFFY #ANTICORPS #POLYMORPHISMES #HABITATION FRONTALIERE #P #VIVAX #PROTEINA DE UNION AL DUFFY #ANTICUERPOS #POLIMORFISMOS #EMPLAZAMIENTO FRONTERIZO #NATURALLY ACQUIRED ANTIBODIES #RECEPTOR-BINDING #VACCINE CANDIDATE #BRAZILIAN AMAZON #LIGAND DOMAIN #INHIBITORY ANTIBODIES #RISK-FACTORS #MALARIA #TRANSMISSION #RECOGNITION #PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH #TROPICAL MEDICINE |
Tipo |
article original article publishedVersion |